4//SEC Filing
Duke William E. 4
Accession 0001209191-23-032167
CIK 0001814140other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:21 PM ET
Size
6.8 KB
Accession
0001209191-23-032167
Insider Transaction Report
Form 4
Apexigen, Inc.APGN
Duke William E.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-05-23$0.40/sh−17,261$6,904→ 158,921 total - Award
Common Stock
2023-05-23+150,000→ 176,182 total
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs. Upon signing of the merger agreement between the Issuer and Pyxis Oncology, Inc. dated May 23, 2023, 60,000 RSUs vested. The remaining 90,000 RSUs vest on the earlier of (i) the closing of the merger or (ii) September 30, 2023.
- [F2]The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.
Documents
Issuer
Apexigen, Inc.
CIK 0001814140
Entity typeother
Related Parties
1- filerCIK 0001636135
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:21 PM ET
- Size
- 6.8 KB